When was Cradle founded?

Cradle was founded in 2021 and raised its 1st funding round 1 year after it was founded.

Where is Cradle located?

Cradle is headquartered in Zurich, Switzerland.

Who is the current CEO of Cradle?

Stef Van Grieken of Cradle. They have also founded 1 company and are angel investors in 2 startups.

How many employees does Cradle have?

As of Jun 30, 2026, the latest employee count at Cradle is 124.

Is Cradle a funded company?

Cradle is a funded company, having raised a total of $103M across 3 funding rounds to date. The company's 1st funding round was a $***** Seed round, raised on Nov 17, 2022.

When was the latest funding round of Cradle?

Cradle's latest funding was a $***** Series B round on Nov 26, 2024, with participation from 3 investors.

Where does Cradle rank among its competitors?

Cradle ranks 3rd amongst 79 active competitors, of which 42 are funded. It stands 9th in terms of total funding among its competitors. The most recent competitor to raise funding was Profluent Bio, which secured $106M in Nov, 2025.

Who are the top competitors of Cradle?

Cradle's top competitors include Nimbus Therapeutics, Generate Biomedicines and EvolutionaryScale. Among them, Profluent Bio secured the most recent funding round in November, 2025.

Cradle - 2026 Company Profile, Team, Funding & Competitors

Company Details

Provider of chemoproteomics solutions for protein design and development. The platform enables researchers to design proteins using predictive algorithms and AI design suggestions. It also offers 3D structure prediction, optimizing thermostability and codon expression.

Website: www.cradle.bio/
Email ID: *****@cradle.bio

Key Metrics

Founded Year

2021

Location

Zurich, Switzerland

Stage

Series B

Total Funding

$103M in 3 rounds

Latest Funding Round

Series B, Nov 26, 2024, $*****

Investors

Index Ventures & 8 more

Ranked

3^rd among 79 active competitors

Employee Count

124 as on Jun 30, 2026

Investment & Acquisitions

BIOGENES TECHNOLOGIES

Similar Companies

OpenEvidence & 2422 more

View Cradle's full profile

Cradle has raised a total funding of $103M over 3 rounds. Its first funding round was on Nov 17, 2022. Its latest funding round was a Series B round on Nov 26, 2024 for $*****. 3 investors participated in its latest round. Cradle has 5 institutional investors and 4 angel investors.

Here is the list of recent funding rounds of Cradle:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Nov 26, 2024	3228299	Series B	1370410	5765232	2074385	5502597
Nov 27, 2023	4855364	Series A	2012662	1741553	7037201	Kindred Capital & 2 more
Nov 17, 2022	6259918	Seed	5507701	3385472	Index Ventures & 1 more	Feike Sijbesma & 1 more

Access funding benchmarks and valuations. Sign up today!

View details of Cradle's funding rounds and investors

The founders of Cradle are Jelle Prins and Stef Van Grieken. Stef Van Grieken is the CEO of Cradle.

Here are the details of Cradle's key team members:

Jelle Prins: Co-Founder of Cradle and founder of 1 other company. They are also an angel investor in 2 startups.
Contact Info: 1 email address
Stef Van Grieken: Co-Founder & CEO of Cradle. They are also an angel investor in 2 startups.
Contact Info: 1 email address

View details of Cradle's Founder profiles and Board Members

Cradle's employee count trend

Cradle has 124 employees as of Jun 26. Here is Cradle's employee count trend over the years:

Uncover Cradle's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Cradle include Nimbus Therapeutics, Generate Biomedicines and EvolutionaryScale. Here is the list of Top 10 competitors of Cradle, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Nimbus Therapeutics 2009, Cambridge (United States), Series F	Developer of targeted therapeutics for cancer, metabolic and inflammatory diseases	$637M	BVF Partners, Atlas Venture & 20 others	68/100
2nd	Generate Biomedicines 2018, Somerville (United States), Public	Developer of a platform for generating novel protein-based therapeutic modalities	$693M	NVentures, Amgen & 14 others	66/100
3rd	Cradle 2021, Zurich (Switzerland), Series B	Provider of chemoproteomics solutions for protein design and development	$103M	IVP, Kindred Capital & 7 others	64/100
4th	EvolutionaryScale 2023, New York City (United States), Seed	Provider of an AI models for protein design	$142M	Lux Capital, Amazon & 3 others	64/100
5th	Frontier Medicines 2018, San Francisco (United States), Series C	Developer of a bioinformatics platform for drug development and chemoproteomics	$236M	Deerfield, RA Capital Management & 11 others	64/100
6th	Profluent Bio 2022, Berkeley (United States), Series B	Provider of an artificial intelligence-based protein design platform	$150M	Insight Partners, Spark Capital & 6 others	64/100
7th	Eikon 2019, Millbrae (United States), Public	Protein tracking and measuring tool for drug discovery	$1.16B	The Column Group, Foresite Capital & 22 others	62/100
8th	Seismic 2019, Watertown (United States), Series B	AI-assisted platform for drug discovery and development	$247M	Lightspeed Venture Partners, Bessemer Venture Partners ... & 12 others	62/100
9th	Vividion Therapeutics 2016, Oceanside (United States), Acquired	Pioneering chemoproteomics and covalent chemistry for precision therapeutics targeting undruggable disease drivers	$271M	Boxer Capital, Versant Ventures & 21 others	61/100
10th	Orbit Discovery 2015, Oxford (United Kingdom), Series A	Developer of a drug discovery platforms by peptide display engine	$15.7M	Oxford Science Enterprises, Innovate UK & 11 others	59/100